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Aim of the study
Hepatocellular carcinoma (HCC) is the most common
malignant liver disease, endemic in the third world
because of its relation with HBV and HCV viral infection.
Given the multiple etiologies of the disease, HCC trend of
incidence is destined to grow in the future. HCC is often
associated with cirrhosis, which is a limit to the surgery in
relation to the functional state of the organ. It is more fre-
quent after 60 years and is often diagnosed after age 70, in
patients with multiple co-morbidity. This work will assess
whether liver resection offers the same advantages in
terms of survival in the elderly (over 70 years) than the
younger population.
Materials and methods
We report our experience based on a series of 127 non-
selected patients submitted to liver resection from Sep-
tember 1989 to January 2007. Patients were divided into
two groups depending on age: Group 1 consists of 100
patients under 70 years old (mean age of 60.34 years),
Group 2 consists of 27 patients over 70 years (mean age of
73.85 years). Frequencies and percentages have been
adopted to summarize qualitative variables, while tools of
descriptive statistics such as mean (± SD, standard devia-
tion) and median was used for quantitative numerical var-
iables. Survival was calculated using the Kaplan-Meier
method, and differences were estimated by the Log-rank
test. The Cox regression model was applied to determine
independent variables that may influence survival. The
multivariate analysis method was applied to analyze inde-
pendent variables affecting survival and disease-free sur-
vival. Significant difference was defined as p < 0.05. The
statistical analysis was conducted using the software for
Windows SPSS 13.0 Evaluation Version (SPSS, Inc., Chi-
cago, IL, USA).
Results
The two groups were compared by sex, etiology, underly-
ing liver disease (HBV, HCV, alcohol, or multifactorial),
presence or absence of cirrhosis (and Child-Pough func-
tional status), grading, tumor size, number of lesions,
absence of capsule, type of liver resection "minor" (= 2
segments) or "major" (≥3 segments), amount of blood
transfusions, tumor markers, and complications. For
none of these characteristics we found statistically signifi-
cant differences except for higher values of alpha fetopro-
tein (AFP) in elderly patients (p = 0.04). In Group 1, 13
patients (13%) were submitted to right hepatectomy, 6
(6%), to left hepatectomy, 16 (16%) to bisegmentectomy,
30 (30%) to segmentectomy and 33 (33%) to wedge
resection. In Group 2, 3 patients (11.5%) were referred to
right hepatectomy, 4 (15.4%) to left hepatectomy, 2
(7.7%) to bisegmentectomy, 9 (34.6%) to segmentec-
tomy and finally 41 (33%) to wedge resections. Post-oper-
ative mortality (within 30 days from surgery) was 5.5% (7
cases), 5 patients died in the first group (5.1%) and 2 in
the second (7.4%) (ns). The rate of complications was
49.4% in 1st group and 40% in 2nd group (ns). The actu-
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arial survival rate at 1, 3 and 5 years was respectively
73.6%, 42.0%, 25.0% in 1st group and 72.2%, 32.5% and
5% in 2nd group (ns). The disease-free survival at 1, 3 and
5 years was 84.0%, 42.6% and 19% in 1st group and
37.5%, 18.8% and 0 in Group 2 (p = 0016, Figure 1).
Among the pathologic variables considered, diameter >5
cm had a negative impact only in the group of young
patients (median survival of 48.4 vs. 36.4 months, p =
0.08). In the 1st group an AFP value >100 was predictive
of poor outcome (median survival of 46.9 vs. 26.8
months, p = 0006). The presence of 2 or more HCC had a
negative but not significantly impact on survival in the
group of elderly (median survival of 29.2 months and 24,
p = 0.09). A volumetric index >40% was a negative prog-
nostic factor in young patients (42, 9 vs. 22.9 months, p =
0.06). The rate of relapse among the two groups was
found to overlap (27.6% in 1st and 26.9% in 2nd group).
Finally, the absence of free margin, the volume of transfu-
sion, and type of resection did not influence survival in
any group.
Conclusion
Surgical treatment of HCC is feasible also in the elderly
patient. The rate of complications and post-operative
mortality are not significantly higher in elderly, although
our data suggests that the long-term outcome is less favo-
rable. For this reason selection of patients over 70 years
would be more accurate to offer same results in terms of
disease-free survival than expected in the young patients.
Disease-free survival by age groupsFigure 1
Disease-free survival by age groups.Page 2 of 2
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